included_article_id,index,GDG,question_id,included_postfulltext,included_reference,same_study_diff_article,notes,author_1_extract,year_pub_extract,author_year_format,included_article_doi,included_article_pmid,oa_id,ss_id,title_if_unavailable,id_sent_apiretrieval,pmid,doi,api_id_retrieved,title,abstract,publication_year,venue,doi.1,mesh_headings,authors,url,pmid.1,api_retrieval_success
3,2,1,1.2,16,"Imran H. J, Dhaher S. A, Mansour M. A. A. Testosterone or Dehydroepiandrosterone Sulfate as A Biomarker for Hirsutism in Women with Polycystic Ovary Syndrome. Biomed Pharmacol J 2020;13(4). DOI: https://dx.doi.org/10.13005/bpj/2056 ",primary_citation,,Imran H. J,2020,"Imran H. J et al., 2020",10.13005/bpj/2056,,,,,10.13005/bpj/2056,,10.13005/bpj/2056,,Testosterone or Dehydroepiandrosterone Sulfate as a Biomarker for Hirsutism in Women with Polycystic Ovary Syndrome,,,,,,,,,0
8,7,1,1.2,16,"Kumar H, Halder A, Sharma M, Jain M, Kalsi AK.Dihydrotestosterone- A Potential Biomarker of Hyperandrogenaemia in Polycystic Ovary Syndrome: A Case-control Study from North IndiaJ Clin of Diagn Res.2022; 16(2):QC09-QC14. https://www.doi.org/10.7860/JCDR/2022/51169.15962 ",primary_citation,,Kumar H,2022,"Kumar H et al., 2022",10.7860/JCDR/2022/51169.15962,,,246715314.0,,,,,,Dihydrotestosterone- A Potential Biomarker of Hyperandrogenaemia in Polycystic Ovary Syndrome: A Case-control Study from North India,,,,,,,,,0
9,8,1,1.2,16,"Koskinen, P., T. A. Penttila, et al. (1996). ""Optimal use of hormone determinations in the biochemical diagnosis of the polycystic ovary syndrome."" Fertil Steril. 1996 Mar;65(3):517-22. doi: 10.1016/s0015-0282(16)58146-1",primary_citation,,Koskinen,1996,"Koskinen et al., 1996",10.1016/s0015-0282(16)58146-1,,,21873315.0,,,,,,Optimal use of hormone determinations in the biochemical diagnosis of the polycystic ovary syndrome,,,,,,,,,0
21,20,1,1.3,7,"Imran H. J, Dhaher S. A, Mansour M. A. A. Testosterone or Dehydroepiandrosterone Sulfate as A Biomarker for Hirsutism in Women with Polycystic Ovary Syndrome. Biomed Pharmacol J 2020;13(4).",primary_citation,,Imran H. J,2020,"Imran H. J et al., 2020",10.13005/bpj/2056,,,,,10.13005/bpj/2056,,10.13005/bpj/2056,,Testosterone or Dehydroepiandrosterone Sulfate as a Biomarker for Hirsutism in Women with Polycystic Ovary Syndrome,,,,,,,,,0
22,21,1,1.3,7,"Kumar, H., Halder, A., Sharma, M., Jain, M., & Kalsi, A. (2022). Dihydrotestosterone- A Potential Biomarker of Hyperandrogenaemia in Polycystic Ovary Syndrome: A Case-control Study from North India. JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH. doi: 10.7860/jcdr/2022/51169.15962",primary_citation,,Kumar,2022,"Kumar et al., 2022",10.7860/jcdr/2022/51169.15962,,,,,10.7860/jcdr/2022/51169.15962,,10.7860/jcdr/2022/51169.15962,,Dihydrotestosterone- A Potential Biomarker of Hyperandrogenaemia in Polycystic Ovary Syndrome: A Case-control Study from North India,,,,,,,,,0
38,37,1,"1.4.1, 1.4.2",27,"Fulghesu AM, Ciampelli M, Belosi C, Apa R, Pavone V, Lanzone A. A new ultrasound criterion for the diagnosis of polycystic ovary syndrome: ovarian stroma/total area ratio. Fertil Steril 2001;76:326–331. DOI: 10.1016/s0015-0282(01)01919-7",primary_citation,,Fulghesu AM,2001,"Fulghesu AM et al., 2001",10.1016/s0015-0282(01)01919-7,,,2551667.0,,,,,,A new ultrasound criterion for the diagnosis of polycystic ovary syndrome: the ovarian stroma/total area ratio,,,,,,,,,0
54,53,1,"1.5.1, 1.5.2",53,"Agrawal, N.; Sharma, R. Correlation of anti-müllerian hormone with clinical, hormonal and ultrasonographic parameters in pcos and normo-ovulatory women: An experience of single tertiary care center. Ital J Gynaecol Obstet 2018;30(4):37-43.",primary_citation,,Agrawal,2018,"Agrawal et al., 2018",10.9790/0853-1602085156,,,52258305.0,,,,,,"Correlation of Anti-Mullerian Hormone with clinical, hormonal and ultrasonographic parameters in PCOS and normo-ovulatory women",,,,,,,,,0
56,55,1,"1.5.1, 1.5.2",53,"Al-Jefout M, Alnawaiseh C, Saleh M, Warwar K. Anti-Müllerianhormone (AMH) new cutoff as a possible tool for thediagnosis of polycystic ovary syndrome (PCOS). J Biomed Sci Res. 2021;3(2):139. Doi: 10.36266/JBSR/139.",primary_citation,,Al-Jefout M,2021,"Al-Jefout M et al., 2021",10.36266/JBSR/139,,,,,,,,,,,,,,,,,,0
57,56,1,"1.5.1, 1.5.2",53,"Al-Naffakh AS, Risan FA. Assessment of anti-Mullerian hormone and anti ovarian antibody in the sera of patients with polycystic ovarian syndrome in AL-Najaf Al-Ashraf Province. Medico-Legal Update 2020;20(1):600–8. Doi: 10.37506/v20/i1/2020/mlu/194384.",primary_citation,,Al-Naffakh AS,2020,"Al-Naffakh AS et al., 2020",10.37506/v20/i1/2020/mlu/194384,,,,,10.37506/v20/i1/2020/mlu/194384,,10.37506/v20/i1/2020/mlu/194384,,Assessment of Anti-Mullerian Hormone and Anti Ovarian Antibody in the Sera of Patients with Polycystic Ovarian Syndrome in AL-Najaf Al-Ashraf Province,,,,,,,,,0
69,68,1,"1.5.1, 1.5.2",53,"Farooq S, Baloch S, Awan S, Fakharunissa. Relationship of Anti-Mullerian Hormone in Polycystic Ovary Syndrome Patients with Different Subgroups. Pak J Med Health Sci 2022;16(5):612-615. No doi",primary_citation,,Farooq S,2022,"Farooq S et al., 2022",10.53350/pjmhs22165612 ,,,,,10.53350/pjmhs22165612,,10.53350/pjmhs22165612,,Relationship of Anti-Mullerian Hormone in Polycystic Ovary Syndrome Patients with Different Subgroups,,,,,,,,,0
71,70,1,"1.5.1, 1.5.2",53,"Gabr H, Marei ES, The Relation between Anti-Mullerian Hormone with Antral Follicle Count and Ovarian Volume in Polycystic Ovary Syndrome. Arab Journal of Nuclear Sciences and Applications 2019;52(2):84-93. ",primary_citation,,Gabr H,2019,"Gabr H et al., 2019",10.21608/ajnsa.2019.3711.1087,,,,,10.21608/ajnsa.2019.3711.1087,,10.21608/ajnsa.2019.3711.1087,,Relation between Anti-Müllerian Hormone with Antral Follicle Count and Ovarian Volume in Polycystic Ovary Syndrome,,,,,,,,,0
78,77,1,"1.5.1, 1.5.2",53,"Kumari A, Tiwari HC, Srivastav R. Comparative Evaluation of Diagnostic Efficacy of Serum Anti-Müllerian Hormone and Ultrasound in Polycystic Ovarian Syndrome. J South Asian Feder Obs Gynae 2018; 10 (2):98-103",primary_citation,,Kumari A,2018,"Kumari A et al., 2018",10.5005/jp-journals-10006-1569,,,,,10.5005/jp-journals-10006-1569,,10.5005/jp-journals-10006-1569,,Comparative Evaluation of Diagnostic Efficacy of Serum Anti-Müllerian Hormone and Ultrasound in Polycystic Ovarian Syndrome,,,,,,,,,0
85,84,1,"1.5.1, 1.5.2",53,"Okcu NT, Nazik H, Akduman AT, Uncu G. The relation between the serum anti-Mullerian hormone levels and follicle count in polycystic ovary syndrome. The European Research Journal. P -2149-3189;4;N1 doi: 10.18621/eurj.332118",primary_citation,,Okcu NT,,"Okcu NT et al., ",10.18621/eurj.332118,,,,,10.18621/eurj.332118,,10.18621/eurj.332118,,The relation between serum anti-Mullerian hormone levels and follicle count in polycystic ovary syndrome,,,,,,,,,0
94,93,1,"1.5.1, 1.5.2",53,"Sharma P, Chawla R, Ahuja R, et al. Anti-Müllerian Hormone as a Surrogate Marker for Hormonal Dysfunction and Sonographic Pattern in Polycystic Ovarian Syndrome. J South Asian Feder Obst Gynae 2019;11(3):175–180. doi: 10.5005/jp-journals-10006-1674",primary_citation,,Sharma P,2019,"Sharma P et al., 2019",10.5005/jp-journals-10006-1674,,,,,10.5005/jp-journals-10006-1674,,10.5005/jp-journals-10006-1674,,Anti-Müllerian Hormone as a Surrogate Marker for Hormonal Dysfunction and Sonographic Pattern in Polycystic ovarian syndrome,,,,,,,,,0
96,95,1,"1.5.1, 1.5.2",53,"Singh S, Firdaus A, Choudhary R, Dhama V. Role of antimullerian hormone as a diagnostic tool for polycystic ovary syndrome. Int J Reprod Contracept Obstet Gynecol. 2020;9(9):3730. DOI: 10.18203/2320-1770.ijrcog20203847.",primary_citation,,Singh S,2020,"Singh S et al., 2020",10.18203/2320-1770.ijrcog20203847,,,,,10.18203/2320-1770.ijrcog20203847,,10.18203/2320-1770.ijrcog20203847,,Role of anti-mullerian hormone as a diagnostic tool for polycystic ovary syndrome,,,,,,,,,0
101,100,1,"1.5.1, 1.5.2",53,"Tunҫ S, and Ozkan B. Analysis of New Biomarkers for the Diagnosis of Polycystic Ovary Syndrome in Adolescents Ergenlerde Polikistik Over Sendromu Tanisi icin Yeni Biyobelirteclerin Analizi. The Journal of Current Pediatrics, vol. 19, no. 3, Dec. 2021, pp. 311+. Gale OneFile: Health and Medicine.",primary_citation,,Tunҫ S,2021,"Tunҫ S et al., 2021",10.4274/jcp.2021.22599,,,,,10.4274/jcp.2021.22599,,10.4274/jcp.2021.22599,,Analysis of New Biomarkers for the Diagnosis of Polycystic Ovary Syndrome in Adolescents,,,,,,,,,0
114,113,1,1.6,47,"Knochenhauer ES, Key TJ, Kahsar-Miller M, Waggoner W, Boots LR, Azziz R. Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. Journal of Clinical Endocrinology & Metabolism. 1998;83(9):3078-3082. doi: 10.1210/jcem.83.9.5090",primary_citation,,Knochenhauer ES,1998,"Knochenhauer ES et al., 1998",10.1210/jcem.83.9.5090,,,,,,,,,Prevalence of the Polycystic Ovary Syndrome in Unselected Black and White Women of the Southeastern United States: A Prospective Study<sup>1</sup>,,,,,,,,,0
119,118,1,1.6,47,"Deswal R, Dang AS, Nanda S. Prevalence of Poly Cystic Ovary Syndrome (PCOS) in North Indian women. Indian Journal of Health and Wellbeing. 2014;5(6):742-744.",primary_citation,,Deswal R,2014,"Deswal R et al., 2014",,,W2221924240,,Prevalence of Poly Cystic Ovary Syndrome (PCOS) in North Indian women,,,,,Prevalence of Poly Cystic Ovary Syndrome (PCOS) in North Indian women,,,,,,,,,0
123,122,1,1.6,47,"Vidya Bharathi R, Swetha S, Neerajaa J, et al. An epidemiological survey: Effect of predisposing factors for PCOS in Indian urban and rural population. Middle East Fertility Society Journal. 2017;22(4):313-316. doi: 10.1016/j.mefs.2017.05.007",primary_citation,,Vidya Bharathi R,2017,"Vidya Bharathi R et al., 2017",10.1016/j.mefs.2017.05.007,,,,,10.1016/j.mefs.2017.05.007,,10.1016/j.mefs.2017.05.007,,An epidemiological survey: Effect of predisposing factors for PCOS in Indian urban and rural population,,,,,,,,,0
125,124,1,1.6,47,"Asuncion M, Calvo RM, San Millan JL, Sancho J, Avila S, Escobar-Morreale HF. A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. Journal of Clinical Endocrinology & Metabolism. 2000;85(7):2434-2438. doi: 10.1210/jcem.85.7.6682",primary_citation,,Asuncion M,2000,"Asuncion M et al., 2000",10.1210/jcem.85.7.6682,,,,,,,,,A Prospective Study of the Prevalence of the Polycystic Ovary Syndrome in Unselected Caucasian Women from Spain1,,,,,,,,,0
138,137,1,1.6,47,"Salehpour S, Shirvani HE, Entezari A. Evaluation of the prevalence of polycystic ovarian syndrome among adolescent (15-18 years old) girls in Tehran during 2005-2006. International Journal of Fertility and Sterility. 2010;4(3):122-127.",primary_citation,,Salehpour S,2005,"Salehpour S et al., 2005",10.22074/ijfs.2010.45808,,,,,,,,,Evaluation of the Prevalence of Polycystic Ovarian Syndrome among Adolescent (15-18 Years Old) Girls in Tehran during 2005-2006,,,,,,,,,0
139,138,1,1.6,47,"Sharif E, Rahman S, Zia Y, Rizk NM. The frequency of polycystic ovary syndrome in young reproductive females in Qatar. Int J Womens Health. 2017;9:1-10. doi: 10.2147/IJWH.S120027",primary_citation,,Sharif E,2017,"Sharif E et al., 2017",10.2147/IJWH.S120027,,,,,,,,,The frequency of polycystic ovary syndrome in young reproductive females in Qatar,,,,,,,,,0
143,142,1,1.6,47,"Dashti S, Latiffah Abdul L, Habibah Abdul H, et al. Prevalence of Polycystic Ovary Syndrome among Malaysian Female University Staff. Journal of Midwifery & Reproductive Health. 2019;7(1):1560-1568. doi: 10.22038/jmrh.2018.30370.1329",primary_citation,,Dashti S,2019,"Dashti S et al., 2019",10.22038/jmrh.2018.30370.1329,,,,,10.22038/jmrh.2018.30370.1329,,10.22038/jmrh.2018.30370.1329,,Prevalence of Polycystic Ovary Syndrome among Malaysian Female University Staff,,,,,,,,,0
182,181,1,1.9.1,18,"Begum, N., Arayousuf, N., Farooq, M. S., Chowdhury, M. A. K. & Ferdous, M. Association of Impaired Glucose Tolerance and Insulin Resistance in Women with Polycystic Ovary Syndrome. Bangladesh Journal of Obstetrics and Gynecology 34(2), 93-98, doi:https://dx.doi.org/10.3329/BJOG.V34I2.58273 (2019).",primary_citation,,Begum,2019,"Begum et al., 2019",10.3329/BJOG.V34I2.58273,,,,,10.3329/bjog.v34i2.58273,,10.3329/bjog.v34i2.58273,,Association of Impaired Glucose Tolerance and Insulin Resistance in Women with Polycystic Ovary Syndrome,,,,,,,,,0
186,185,1,1.9.1,18,"Fuad, Z. F. & Alobaidy, E. J. Association of hba1c levels with body mass index in a patient diagnosed with polycystic ovary syndrome. Indian Journal of Public Health Research and Development 9(7), 298-303, doi:https://dx.doi.org/10.5958/0976-5506.2018.00659.9 (2018).",primary_citation,,Fuad,2018,"Fuad et al., 2018",10.5958/0976-5506.2018.00659.9,,,,,10.5958/0976-5506.2018.00659.9,,10.5958/0976-5506.2018.00659.9,,Association of HbA1c Levels with Body Mass Index in a Patient Diagnosed with Polycystic Ovary Syndrome,,,,,,,,,0
229,228,1,1.9.1,18,"Sawathiparnich P, Weerakulwattana L, Santiprabhob J, Likitmaskul S. Obese adolescent girls with polycystic ovary syndrome (PCOS) have more severe insulin resistance measured by HOMA-IR score than obese girls without PCOS. Journal of the Medical Association of Thailand 2005;88 Suppl 8:S33–S37.",primary_citation,prior search,Sawathiparnich P,2005,"Sawathiparnich P et al., 2005",,,W96216759,23693651.0,Obese adolescent girls with polycystic ovary syndrome (PCOS) have more severe insulin resistance measured by HOMA-IR score than obese girls without PCOS,,,,,Obese adolescent girls with polycystic ovary syndrome (PCOS) have more severe insulin resistance measured by HOMA-IR score than obese girls without PCOS,,,,,,,,,0
235,234,1,1.9.2,6,"Altemimi MT, Musa AK, Mansour AA. The Performance of Glycated Hemoglobin vs. Oral Glucose Tolerance Test in the Diagnosis of Glycemic Disorders among Women with Polycystic Ovary Syndrome in Southern Iraq. The Indonesian Biomedical Journal. 2021 Jun 14;13(2):178-85.",primary_citation,,Altemimi MT,2021,"Altemimi MT et al., 2021",10.1210/jendso/bvab048.891,,,,,10.1210/jendso/bvab048.891,,10.1210/jendso/bvab048.891,,The Performance of Glycated Hemoglobin Versus Oral Glucose Tolerance Test in the Diagnosis of Glycemic Disorders Among Women With Polycystic Ovary Syndrome in Southern Iraq,,,,,,,,,0
266,265,1,1.11,23,"Uehara, T., Mitsuhashi, A., & Shozu, M. (2020). The impact of pre-existing polycystic ovary syndrome on endometrial cancer recurrence. European Journal Of Gynaecological Oncology, 41(5), 668. doi: 10.31083/j.ejgo.2020.05.5038",primary_citation,,Uehara,2020,"Uehara et al., 2020",10.31083/j.ejgo.2020.05.5038,,,,,10.31083/j.ejgo.2020.05.5038,,10.31083/j.ejgo.2020.05.5038,,The impact of preexisting polycystic ovary syndrome on endometrial cancer recurrence,,,,,,,,,0
277,276,1,1.12,60,"SIR-PETERMANN, T., VANTMAN, N., CONCHA, F., ECHIBURU, B., PEREIRA, C., DE GUEVARA, A. L., CRISOSTO, N. R., PEREZ-BRAVO, F. A. & SANTOS, J. L. 2014. Metabolic Profile and Eating Behavior Score in Prepubertal and Early Pubertal Sons of Women with Polycystic Ovary Syndrome. Endocr. Rev., 35, 2.",samestudy_276,,SIR-PETERMANN,2014,"SIR-PETERMANN et al., 2014",,,,,Metabolic Profile and Eating Behavior Score in Prepubertal and Early Pubertal Sons of Women with Polycystic Ovary Syndrome,,,,,Metabolic Profile and Eating Behavior Score in Prepubertal and Early Pubertal Sons of Women with Polycystic Ovary Syndrome,,,,,,,,,0
282,281,1,1.12,60,"Leblanc, S. H., Leblanc, S., Battista, M. C., Geller, D. H., & Baillargeon, J. P. (2016). Evolution of metabolic alterations 5 years after peri-pubertal years in young girls genetically predisposed to polycystic ovary syndrome compared to age-matched control girls. Endocrine Reviews, 37(2 Supplement 1). doi:https://dx.doi.org/10.1210/endo-meetings.2016.RE.5.SUN-156",samestudy_281,,Leblanc,2016,"Leblanc et al., 2016",10.1210/endo-meetings.2016.RE.5.SUN-156,,,,,,,,,,,,,,,,,,0
293,292,1,1.12,60,"Lenarcik, A., Bidzinska-Speichert, B. and Tworowska-Bardzinska, U. (2011) ‘Metabolic Abnormalities in Siblings of Women with Polycystic Ovary Syndrome’, ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, 20(2), pp. 165–175. ",primary_citation,,Lenarcik,2011,"Lenarcik et al., 2011",,,,74019465.0,Metabolic Abnormalities in Siblings of Women with Polycystic Ovary Syndrome,,,,,Metabolic Abnormalities in Siblings of Women with Polycystic Ovary Syndrome,,,,,,,,,0
297,296,1,1.12,60,"Trottier, A., Battista, M. C., Carpentier, A., Simoneau-Roy, J., Geller, D., & Baillargeon, J. P. (2011). Early metabolic and endocrine perturbations in pre- or peripubertal girls with a first degree relative with polycystic ovary syndrome. Fertility and sterility, 96(3), S129-S129. doi:10.1016/j.fertnstert.2011.07.502",samestudy_296,,Trottier,2011,"Trottier et al., 2011",10.1016/j.fertnstert.2011.07.502,,,,,10.1016/j.fertnstert.2011.07.502,,10.1016/j.fertnstert.2011.07.502,,Early metabolic and endocrine perturbations in pre- or peripubertal girls with a first degree relative with polycystic ovary syndrome,,,,,,,,,0
298,297,1,1.12,60,"Trottier, A., Battista, M. C., Simoneau-Roy, J., Carpentier, A., Geller, D. H., & Baillargeon, J. P. (2011). Early metabolic and endocrine perturbations in first-degree relative adolescent girls of polycystic ovary syndrome women. Endocrine Reviews, 32(3 Meeting Abstracts). ",samestudy_296,,Trottier,2011,"Trottier et al., 2011",10.1016/J.FERTNSTERT.2011.07.502,,W4253108685,,,10.1016/j.fertnstert.2011.07.502,,10.1016/j.fertnstert.2011.07.502,,Early Metabolic and Endocrine Perturbations in First-Degree Relative Adolescent Girls of Polycystic Ovary Syndrome Women,,,,,,,,,0
318,317,1,1.12,60,"Sir-Petermann, T.; Angel, B.; Maliqueo, M.; Perez-Bravo, F. Glucose tolerance, insulin secretion and insulin resistance in parents of women with polycystic ovary sindrome. Diabetologia 2001;44:A86-A86.",samestudy_313,,Sir-Petermann,2001,"Sir-Petermann et al., 2001",10.1007/BF03180172,,,,,10.1007/bf03180172,,10.1007/bf03180172,,"Abstracts of the 37th Annual Meeting of the EASD Glasgow, United Kingdom, 9–13 September 2001",,,,,,,,,0
324,323,1,1.12,60,"TORCHEN, L., FOGEL, N. R., BRICKMAN, W., PAPARODIS, R. & DUNAIF, A. 2013. Persistent defects in pancreatic beta-cell function in early pubertal female relatives of women with polycystic ovary syndrome in a three year longitudinal study. Endocrine Reviews, 34.",samestudy_323,,TORCHEN,2013,"TORCHEN et al., 2013",,,,,Persistent defects in pancreatic beta-cell function in early pubertal female relatives of women with polycystic ovary syndrome in a three year longitudinal study,,,,,Persistent defects in pancreatic beta-cell function in early pubertal female relatives of women with polycystic ovary syndrome in a three year longitudinal study,,,,,,,,,0
325,324,1,1.12,60,"TORCHEN, L. C., FOGEL, N. R., BRICKMAN, W. J., MAURAS, N. & DUNAIF, A. 2012. Beta-cell dysfunction and hyperandrogenemia in PCOS early pubertal female relatives. Endocrine Reviews, 33.",samestudy_323,,TORCHEN,2012,"TORCHEN et al., 2012",,,,,Beta-cell dysfunction and hyperandrogenemia in PCOS early pubertal female relatives,,,,,Beta-cell dysfunction and hyperandrogenemia in PCOS early pubertal female relatives,,,,,,,,,0
339,338,2,2.1.1 / 2.1.2,36,"Jose, S. A.; Ravi, R.; Murthy, M. K. Quality of life in women with polycystic ovarian syndrome: Requisite of clinical pharmacist intervention. Asian Journal of Pharmaceutical and Clinical Research. Conference: 3rd International Conference on Academic and Industrial Innovations: Transitions in Pharmaceutical, Medical and Biosciences, INNOPHARM 2018;11(11): 2018",primary_citation,,Jose,2018,"Jose et al., 2018",10.22159/ajpcr.2019.v12i11.34426,,,,,10.22159/ajpcr.2019.v12i11.34426,,10.22159/ajpcr.2019.v12i11.34426,,QUALITY OF LIFE IN WOMEN WITH POLYCYSTIC OVARIAN SYNDROME: REQUISITE OF CLINICAL PHARMACIST INTERVENTION,,,,,,,,,0
344,343,2,2.1.1 / 2.1.2,36,"Lidaka, L.; Lazdane, G.; Kivite-Urtane, A.; Gailite, L.; Dzivite-Krisane, I.; Stokenberga, I. Health-related quality of life and binge eating among adolescent girls with PCOS. Clinical and Experimental Obstetrics and Gynecology 2019;46(5)():831-832",primary_citation,,Lidaka,2019,"Lidaka et al., 2019",10.31083/j.ceog4903057,,,,,10.31083/j.ceog4903057,,10.31083/j.ceog4903057,,Health-related quality of life and binge eating among adolescent girls with PCOS,,,,,,,,,0
374,373,2,2.2,80,"Erson Aksu, Elmas Beyazyüz, Yakup Albayrak, Nihan Potas, Ferit Durankuş, Gamze Uvaçin & Murat Beyazyüz (2019) Altered cooperativeness in patients with polycystic ovary syndrome, Psychiatry and Clinical Psychopharmacology, 29:4, 880-886, DOI: 10.1080/24750573.2019.1691357",primary_citation,,Erson Aksu,2019,"Erson Aksu et al., 2019",10.1080/24750573.2019.1691357,,,,,10.1080/24750573.2019.1691357,,10.1080/24750573.2019.1691357,,Altered cooperativeness in patients with polycystic ovary syndrome,,,,,,,,,0
376,375,2,2.2,80,"Altinkaya, O., Nergiz, S., Kucuk, M., & Yuksel, H. (2014). Depression and anxiety in relation with hormonal and metabolic profile in women with polycystic ovarian syndrome. Turkiye Klinikleri J Gynecol Obst, 24(3), 159-65.",primary_citation,,Altinkaya,2014,"Altinkaya et al., 2014",,,W1524022481,59115787.0,Beta-cell dysfunction and hyperandrogenemia in PCOS early pubertal female relatives,,,,,Beta-cell dysfunction and hyperandrogenemia in PCOS early pubertal female relatives,,,,,,,,,0
392,391,2,2.2,80,"Caltekin, M., Hamamci, M., Onat, T., Kirmizi, D., Baser, E., & Yalvac, E. (2021). Evaluation of Sleep Quality, Restless Legs Syndrome, Anxiety and Depression in Polycystic Ovary Syndrome. Journal Of Turkish Sleep Medicine, 3, 243-249.",primary_citation,,Caltekin,2021,"Caltekin et al., 2021",10.4274/jtsm.galenos.2021.85057,,,,,10.4274/jtsm.galenos.2021.85057,,10.4274/jtsm.galenos.2021.85057,,"Evaluation of Sleep Quality, Restless Legs Syndrome, Anxiety and Depression in Polycystic Ovary Syndrome",,,,,,,,,0
408,407,2,2.2,80,"HARMANCI, H., HERGÜNER, S., & TOY, H. (2013). Polikistik Over Sendromu olan Kadınlarda Psikiyatrik Belirtiler / Psychiatric Symptoms in Women with Polycystic Ovary Syndrome. Dusunen Adam: The Journal Of Psychiatry And Neurological Sciences, 26, 157-163. doi: 10.5350/dajpn2013260205",primary_citation,,HARMANCI,2013,"HARMANCI et al., 2013",10.5350/dajpn2013260205,,,,,10.5350/dajpn2013260205,,10.5350/dajpn2013260205,,Polikistik Over Sendromu olan Kadınlarda Psikiyatrik Belirtiler / Psychiatric Symptoms in Women with Polycystic Ovary Syndrome,,,,,,,,,0
429,428,2,2.2,80,"Mukundan, A., & Jayakumari, S. (2019). RISK OF DEVELOPING DEPRESSION AND ITS IMPACT ON QUALITY OF LIFE IN PATIENTS WITH POLYCYSTIC OVARY SYNDROME - A SOUTH INDIAN SCENARIO. International Journal Of Pharmaceutical Sciences And Research, 10(6), 2956-2961.",primary_citation,,Mukundan,2019,"Mukundan et al., 2019",10.13040/IJPSR.0975-8232.10(6).2956-61,,,212468337.0,,,,,,RISK OF DEVELOPING DEPRESSION AND ITS IMPACT ON QUALITY OF LIFE IN PATIENTS WITH POLYCYSTIC OVARY SYNDROME-A SOUTH INDIAN SCENARIO,,,,,,,,,0
432,431,2,2.2,80,"Ozenli, Y., Haydardedeoglu, B., Micozkadioglu, I., Simsek, E., Bulgan Kilicdag, E., & Bagis, T. (2008). Anxiety, Depression and Ways of Coping Skills by Women with Polycystic Ovary Syndrome: A Controlled Study. J Turkish-German Gynecol Assoc, 9(4), 190-194.",primary_citation,,Ozenli,2008,"Ozenli et al., 2008",,,,146131120.0,"Anxiety, Depression and Ways of Coping Skills by Women with Polycystic Ovary Syndrome: A Controlled Study",,,,,"Anxiety, Depression and Ways of Coping Skills by Women with Polycystic Ovary Syndrome: A Controlled Study",,,,,,,,,0
441,440,2,2.2,80,"Soyupek, F., Yildiz, S., Akkus, S., Guney, M., Mungan, M., & Eris, S. (2010). The Frequency of Fibromyalgia Syndrome in Patients with Polycystic Ovary Syndrome. Journal Of Musculoskeletal Pain, 18(2), 120-126. doi: 10.3109/10582452.2010.483968",primary_citation,,Soyupek,2010,"Soyupek et al., 2010",10.3109/10582452.2010.483968,,,,,10.3109/10582452.2010.483968,,10.3109/10582452.2010.483968,,The Frequency of Fibromyalgia Syndrome in Patients with Polycystic Ovary Syndrome,,,,,,,,,0
454,453,2,2.3,29,"Elkhiat, Y., Zedan, A., Mostafa, M. and Elhalwagi, A., (2015). Sexual desire in a sample of married Egyptian women with polycystic ovarian syndrome. Human Andrology. 2015; 5(3):49-57. DOI:10.1097/01.XHA.0000470182.71509.1b",primary_citation,prior search,Elkhiat,2015,"Elkhiat et al., 2015",10.1097/01.XHA.0000470182.71509.1b,,,,,10.1097/01.xha.0000470182.71509.1b,,10.1097/01.xha.0000470182.71509.1b,,Sexual desire in a sample of married Egyptian women with polycystic ovarian syndrome,,,,,,,,,0
458,457,2,2.3,29,"Gateva, A. and Kamenov, Z., (2012). Sexual Function in Patients with PCOS and/or Obesity before and after Metformin Treatment. Advances in Sexual Medicine. 2012.  DOI: 10.4236/asm.2012.22005.",primary_citation,prior search,Gateva,2012,"Gateva et al., 2012",10.4236/asm.2012.22005,,,,,10.4236/asm.2012.22005,,10.4236/asm.2012.22005,,Sexual Function in Patients with PCOS and/or Obesity before and after Metformin Treatment,,,,,,,,,0
476,475,2,2.3,29,"Mantzou, D, Stamou, MI, Armeni, AK, Roupas, ND, Assimakopoulos, K, Adonakis, G, Georgopoulos, NA & Markantes, GK. (2021). Impaired sexual function in young women with PCOS: the detrimental effect of anovulation. J Sexual Medicine, 2021;18:1872-1879. doi.org/10.1016/j.jsxm.2021.09.004",primary_citation,,Mantzou,2021,"Mantzou et al., 2021",10.1016/j.jsxm.2021.09.004,,,,,pmid:37057487,pmid:37057487,10.1016/j.jsxm.2021.09.004,,Impaired Sexual Function in Young Women with PCOS: The Detrimental Effect of Anovulation,,,,,,,,,0
478,477,2,2.3,29,"Thagavi, SA, Aramesh, S, Azizi-Kutenaee, M, Allan, H, Safarzadeh, T, Taheri, M, Salari, S, Khashavi & Bazarganipour, F. (2021) The influence of infertility on sexual and marital satisfaction in Iranian women with polycystic ovary syndrome: a case-control study. Middel East Fertilty Society Journal. 2021;26(2). doi.org/10.1186/s43043-020-00047-y",primary_citation,,Thagavi,2021,"Thagavi et al., 2021",10.1186/s43043-020-00047-y,,,,,10.1186/s43043-020-00047-y,,10.1186/s43043-020-00047-y,,The influence of infertility on sexual and marital satisfaction in Iranian women with polycystic ovary syndrome: a case-control study,,,,,,,,,0
490,489,2,2.5,14,"Batcheller, A., Ressler, I., Sroga, J., Martinez, A., Thomas, M., Di Paola, K. (2013). Binge eating disorder in the infertile polycystic ovary syndrome patient. Fertility and Sterility, 2013.",primary_citation,Prior search,Batcheller,2013,"Batcheller et al., 2013",10.1016/J.FERTNSTERT.2013.07.631,,,,,10.1016/j.fertnstert.2013.07.631,,10.1016/j.fertnstert.2013.07.631,,Binge eating disorder in the infertile polycystic ovary syndrome patient,,,,,,,,,0
493,492,2,2.5,14,"Lee, I., Cooney, L., Saini, S., Smith, M., Allison, K. Dokras, A. (2016). Increased risk of eating disorders in women with polycystic ovary syndrome. Fertility and Sterility, 2016.",primary_citation,Prior search,Lee,2016,"Lee et al., 2016",10.1016/J.FERTNSTERT.2016.07.750,,,,,10.1016/j.fertnstert.2016.07.750,,10.1016/j.fertnstert.2016.07.750,,Increased risk of eating disorders in women with polycystic ovary syndrome,,,,,,,,,0
497,496,2,2.5,14,"Maher, M., Sanders, A.(2018). Eating indicators in women with polycystic ovary syndrome and weight-matched controls. FASEB Journal, 2018.",primary_citation,,Maher,2018,"Maher et al., 2018",10.1096/fasebj.31.1_supplement.lb374,,,,,10.1096/fasebj.31.1_supplement.lb374,,10.1096/fasebj.31.1_supplement.lb374,,Eating Indicators In Women With Polycystic Ovary Syndrome And Weight‐Matched Controls,,,,,,,,,0
498,497,2,2.5,14,"Lidaka, L., Lazdane, G., Kivite-Urtane, A., Gailite, L., Dzivite-Krisane, I., Stokenberga, I. (2019). Health-related quality of life and binge eating among adolescent girls with PCOS. Clinical and Experimental Obstetrics and Gynecology, 2019.",primary_citation,,Lidaka,2019,"Lidaka et al., 2019",10.31083/j.ceog4903057,,,,,10.31083/j.ceog4903057,,10.31083/j.ceog4903057,,Health-related quality of life and binge eating among adolescent girls with PCOS,,,,,,,,,0
503,502,2,2.6.1,41,"Arif N, Khawaja S, Iqbal Q. Awareness of Polycystic Ovarian Disease: Knowledge and Presence of Presenting Symptoms. Pakistan Journal of Medical and Health Sciences. 2020;14(2):627-30.",primary_citation,,Arif N,2020,"Arif N et al., 2020",,,,,Awareness of Polycystic Ovarian Disease: Knowledge and Presence of Presenting Symptoms,,,,,Awareness of Polycystic Ovarian Disease: Knowledge and Presence of Presenting Symptoms,,,,,,,,,0
510,509,2,2.6.1,41,"Dutta, D., Bhattacharya, S., Khandelwal, D., Aggarwal, S., Singla, R., Surana, V., & Dhingra, A. (2020). Clinical Practice Patterns of Polycystic Ovary Syndrome Among Doctors of Different Specialtiesâ€”An Indian Perspective. US Endocrinology, 16(2), 74-79.",primary_citation,,Dutta,2020,"Dutta et al., 2020",10.17925/USE.2020.16.2.74,,,,,10.17925/use.2020.16.2.74,,10.17925/use.2020.16.2.74,,Clinical Practice Patterns of Polycystic Ovary Syndrome Among Doctors of Different Specialties—An Indian Perspective,,,,,,,,,0
516,515,2,2.6.1,41,"Salman AD,. Nurses--Midwifes Knowledge Concerning Polycystic Ovary Syndrome in Baghdad Hospitals. Indian Journal of Forensic Medicine & Toxicology. 2020 Oct 1;14(4).",primary_citation,,Salman AD,2020,"Salman AD et al., 2020",10.37506/IJFMT.V14I4.12337,,,,,10.37506/ijfmt.v14i4.12337,,10.37506/ijfmt.v14i4.12337,,Nurses – Midwifes Knowledge Concerning Polycystic Ovary Syndrome in Baghdad Hospitals,,,,,,,,,0
553,552,2,2.6.4,28,"Crete J, Adamshick P. Managing polycystic ovary syndrome: what our patients are telling us. Journal of Holistic Nursing. 2011 Dec;29(4):256-66.",primary_citation,,Crete J,2011,"Crete J et al., 2011",10.1177/0898010111429092,,,,,10.1177/0898010111429092,,10.1177/0898010111429092,,Continuing Nursing Education for “Managing Polycystic Ovary Syndrome: What Our Patients Are Telling Us”,,,,,,,,,0
567,566,2,2.6.4,28,"Sharma S, Mishra AJ. Tabooed disease in alienated bodies: A study of women suffering from Polycystic Ovary Syndrome (PCOS). Clinical Epidemiology and Global Health. 2018 Sep 1;6(3):130-6.",primary_citation,,Sharma S,2018,"Sharma S et al., 2018",10.1016/J.CEGH.2017.09.001,,,,,10.1016/j.cegh.2017.09.001,,10.1016/j.cegh.2017.09.001,,Tabooed disease in alienated bodies: A study of women suffering from Polycystic Ovary Syndrome (PCOS),,,,,,,,,0
592,591,3,3.1,18,"Nasrekani ZA, Fathi M. Efficacy of 12 weeks aerobic training on body composition, aerobic power and some women‐hormones in polycystic ovary syndrome infertile women. Iranian Journal of Obstetrics, Gynecology and Infertility 2016;19(5):1‐10.",primary_citation,prior search,Nasrekani ZA,2016,"Nasrekani ZA et al., 2016",,,,80790917.0,"Efficacy of 12 weeks aerobic training on body composition, aerobic power and some women‐hormones in polycystic ovary syndrome infertile women",,,,,"Efficacy of 12 weeks aerobic training on body composition, aerobic power and some women‐hormones in polycystic ovary syndrome infertile women",,,,,,,,,0
596,595,3,3.1,18,"Saremi A, Nader, Karmali M, Kazemi M. Serum level of anti‐mullerian hormone after exercise training in women with polycystic ovary syndrome: a randomised controlled trial. Iranian Journal of Obstetrics, Gynecology and Infertility 2013;16(64):10.",primary_citation,prior search,Saremi A,2013,"Saremi A et al., 2013",,,W3121804787,, Serum level of anti‐mullerian hormone after exercise training in women with polycystic ovary syndrome: a randomised controlled trial.,,,,, Serum level of anti‐mullerian hormone after exercise training in women with polycystic ovary syndrome: a randomised controlled trial.,,,,,,,,,0
606,605,3,3.3,12,"Hosseini Marnani E., Ghadiri-Anari A., Ramezani-Jolfaie N., Mohammadi M., Abdollahi, A., Namayandeh S. M., et al. Effect of fennel supplementation along with high-protein, low-carbohydrate weight-loss diet on insulin resistance and percentage of fat and muscle mass in overweight/obese women with polycystic ovary syndrome. Journal of Functional Foods 2020 Vol. 67 Pages 103848. https://doi.org/10.1016/j.jff.2020.103848",primary_citation,,Hosseini Marnani E.,2020,"Hosseini Marnani E. et al., 2020",10.1016/j.jff.2020.103848,,,,,10.1016/j.jff.2020.103848,,10.1016/j.jff.2020.103848,,"Effect of fennel supplementation along with high-protein, low-carbohydrate weight-loss diet on insulin resistance and percentage of fat and muscle mass in overweight/obese women with polycystic ovary syndrome",,,,,,,,,0
614,613,3,3.3,12,"Panico A, Lupoli GA, Cioffi I, Zacchia G, Caldara A, Lupoli G, Contaldo F, Pasanisi F. Effects of an isocaloric low-glycemic-load diet in polycystic ovary syndrome. Nutr Ther Metab. 2014;32:85–92.",primary_citation,prior search,Panico A,2014,"Panico A et al., 2014",10.5301/NTM.2014.12407,,,,,10.5301/ntm.2014.12407,,10.5301/ntm.2014.12407,,Effects of an isocaloric low-glycemic-load diet in polycystic ovary syndrome,,,,,,,,,0
626,625,3,3.5,70,"Alipouri, B., Roohelhami, E., Shahrdami, F., & Rashidkhani, B. (2019). Dietary glycemic index/glycemic load and their relationship with inflammatory markers in women with polycystic ovary syndrome. PROGRESS IN NUTRITION, 21, 115-121.",primary_citation,,Alipouri,2019,"Alipouri et al., 2019",10.23751/pn.v21i1-S.5616,,,,,,,,,,,,,,,,,,0
645,644,3,3.5,70,"Gopalan U , Ghose S , Karnaboopathy R , Comparison of dietary pattern and BMI in South Indian women with PCOS and controls. Indian J Obstet Gynecol Res 2021;8(1):57-60",primary_citation,,Gopalan U ,2021,"Gopalan U  et al., 2021",10.18231/J.IJOGR.2021.011,,,,,10.18231/j.ijogr.2021.011,,10.18231/j.ijogr.2021.011,,Comparison of dietary pattern and BMI in South Indian women with PCOS and controls,,,,,,,,,0
676,675,3,3.5,70,"Thara, C., & Divakar, S. U. M. A. (2017). Assessment of nutritional status of PCOS women in Kerala. International Journal of Applied Home Science, 4(9-10), 717-722.",primary_citation,,Thara,2017,"Thara et al., 2017",,,,,Serum level of anti‐mullerian hormone after exercise training in women with polycystic ovary syndrome: a randomised controlled trial,,,,,Serum level of anti‐mullerian hormone after exercise training in women with polycystic ovary syndrome: a randomised controlled trial,,,,,,,,,0
696,695,3,3.6,7,"Chopra, S., Zehrung, R., Shanmugam, T. A., & Choe, E. K. (2021, May). Living with uncertainty and stigma: self-experimentation and support-seeking around polycystic ovary syndrome. In Proceedings of the 2021 CHI Conference on Human Factors in Computing Systems (pp. 1-18). https://doi.org/10.1145/3411764. 3445706",primary_citation,,Chopra,2021,"Chopra et al., 2021",10.1145/3411764,,,,,10.1145/3411764,,10.1145/3411764,,Proceedings of the 2021 CHI Conference on Human Factors in Computing Systems,,,,,,,,,0
702,701,4,4.2 / 4.3,85,"Aghamohammadzadeh N, Aliasgarzadeh A, Baglar L, Abdollahifard S, Bahrami A, Najafipour F, et al. Comparison of metformin and cyproteroneestrodiol compound effect on hs c-reactive protein and serum androgen levels in patients with poly cystic ovary syndrome. Pakistan journal of medical sciences. 2010;26(2):347-51.",primary_citation,,Aghamohammadzadeh N,2010,"Aghamohammadzadeh N et al., 2010",,,,54806151.0,Assessment of nutritional status of PCOS women in Kerala,,,,,Assessment of nutritional status of PCOS women in Kerala,,,,,,,,,0
713,712,4,4.2 / 4.3,85,"Cetinkalp S, Karadeniz M, Erdogan M, Ozgen G, Saygl F, Ylmaz C. The effects of rosiglitazone, metformin, and estradiol-cyproterone acetate on lean patients with polycystic ovary syndrome. The Endocrinologist (Baltimore, Md). 2009;19(3):94-7.",primary_citation,,Cetinkalp S,2009,"Cetinkalp S et al., 2009",10.1097/TEN.0B013E3181A58772,,,,,10.1097/ten.0b013e3181a58772,,10.1097/ten.0b013e3181a58772,,"The Effects of Rosiglitazone, Metformin, and Estradiol-Cyproterone Acetate on Lean Patients With Polycystic Ovary Syndrome",,,,,,,,,0
720,719,4,4.2 / 4.3,85,"El Maghraby HA, Nafee T, Guiziry D, Elnashar A. Randomized controlled trial of the effects of metformin versus combined oral contraceptives in adolescent PCOS women through a 24 month follow up period. Middle East Fertility Society journal. 2015;20(3):131-7.",primary_citation,,El Maghraby HA,2015,"El Maghraby HA et al., 2015",10.1016/J.MEFS.2014.10.003,,,,,10.1016/j.mefs.2014.10.003,,10.1016/j.mefs.2014.10.003,,Randomized controlled trial of the effects of metformin versus combined oral contraceptives in adolescent PCOS women through a 24month follow up period,,,,,,,,,0
743,742,4,4.2 / 4.3,85,"Kebapcilar L, Yuksel A, Bozkaya G, Taner CE, Kebapcilar AG, Bilgir O, et al. Effects of an EE/CA compared with EE/CA-metformin on serum ADMA levels in women with polycystic ovary syndrome. Central European journal of medicine. 2009;4(4):423-7.",primary_citation,,Kebapcilar L,2009,"Kebapcilar L et al., 2009",10.2478/s11536-009-0074-x,,,,,10.2478/s11536-009-0074-x,,10.2478/s11536-009-0074-x,,Effects of an EE/CA compared with EE/CA-metformin on serum ADMA levels in women with polycystic ovary syndrome,,,,,,,,,0
758,757,4,4.2 / 4.3,85,"Meyer C, McGrath BP, Teede HJ. Effects of medical therapy on insulin resistance and the cardiovascular system in polycystic ovary syndrome. Diabetes care. 2007;30(3):471-8.",primary_citation,,Meyer C,2007,"Meyer C et al., 2007",10.2337/DC06-0618,,,,,10.2337/dc06-0618,,10.2337/dc06-0618,,Effects of Medical Therapy on Insulin Resistance and the Cardiovascular System in Polycystic Ovary Syndrome,,,,,,,,,0
761,760,4,4.2 / 4.3,85,"Moran LJ, Meyer C, Hutchison SK, Zoungas S, Teede HJ. Novel inflammatory markers in overweight women with and without polycystic ovary syndrome and following pharmacological intervention. J Endocrinol Invest. 2010;33(4):258-65.",primary_citation,,Moran LJ,2010,"Moran LJ et al., 2010",10.1007/BF03345790,,,,,10.1007/bf03345790,,10.1007/bf03345790,,Novel inflammatory markers in overweight women with and without polycystic ovary syndrome and following pharmacological intervention,,,,,,,,,0
779,778,4,4.2 / 4.3,85,"Taheripanah R, Sepahvandi M, Entezari A, Amiri Z, Samani EN. Evaluation of serum PSA after cyproterone compound treatment compared with oral contraceptive pill in hirsute polycystic ovary syndrome patients. Middle East Fertility Society journal. 2010;15(3):159-62.",primary_citation,,Taheripanah R,2010,"Taheripanah R et al., 2010",10.1016/J.MEFS.2010.06.007,,,,,10.1016/j.mefs.2010.06.007,,10.1016/j.mefs.2010.06.007,,Evaluation of serum PSA after cyproterone compound treatment compared with oral contraceptive pill in hirsute polycystic ovary syndrome patients,,,,,,,,,0
791,790,4,4.4,111,"Chou, K.H., et al., Clinical, metabolic and endocrine parameters in response to metformin in obese women with polycystic ovary syndrome: a randomized, double blind and placebo‐controlled trial. Hormone & Metabolic Research, 2003. 35(2): p. 86‐91. (ROB included in last TR under Patel 2017) ",primary_citation,,Chou,2003,"Chou et al., 2003",10.1055/S-2003-39056,,,,,10.1055/s-2003-39056,,10.1055/s-2003-39056,,"Clinical, Metabolic and Endocrine Parameters in Response to Metformin in Obese Women with Polycystic Ovary Syndrome: A Randomized, Double-Blind and Placebo-Controlled Trial",,,,,,,,,0
797,796,4,4.4,111,"Karimzadeh MA, Eftekhar M, Taheripanah R, Tayebi N, Sakhavat L, Zare F. The effect of administration of metformin on lipid profile changes and insulin resistance in patients with polycystic ovary syndrome. Middle East Fertil Soc J 2007 (ROB included in last TR under Tang 2012)",primary_citation,,Karimzadeh MA,2007,"Karimzadeh MA et al., 2007",,,,35054293.0,The effect of administration of metformin on lipid profile changes and insulin resistance in patients with polycystic ovary syndrome,,,,,The effect of administration of metformin on lipid profile changes and insulin resistance in patients with polycystic ovary syndrome,,,,,,,,,0
828,827,4,4.4,111,"Aghamohammadzadeh N, Aliasgarzadeh A, Baglar L, Abdollahifard S, Bahrami A, Najafipour F, et al. Pregnancy rate in women with pcos with high lh/fsh ratio undergoing icsi. Pakistan Journal of Medical Science 2010",primary_citation,,Aghamohammadzadeh N,2010,"Aghamohammadzadeh N et al., 2010",,,,54806151.0,The effect of administration of metformin on lipid profile changes and insulin resistance in patients with polycystic ovary syndrome,,,,,The effect of administration of metformin on lipid profile changes and insulin resistance in patients with polycystic ovary syndrome,,,,,,,,,0
829,828,4,4.4,111,"El Maghraby HA, Nafee T, Guiziry D, Elnashar A. Randomized controlled trial of the effects of metformin versus combined oral contraceptives in adolescent PCOS women through a 24 months follow up period. Middle East Fertility Society Journal 2015 (ROB included in last TR under Al Khalifa 2016)",primary_citation,,El Maghraby HA,2015,"El Maghraby HA et al., 2015",10.1016/J.MEFS.2014.10.003,,,,,10.1016/j.mefs.2014.10.003,,10.1016/j.mefs.2014.10.003,,Randomized controlled trial of the effects of metformin versus combined oral contraceptives in adolescent PCOS women through a 24month follow up period,,,,,,,,,0
836,835,4,4.4,111,"Meyer C, McGrath BP, Teede HJ. Effect of medical therapy on insulin resistance and the cardiovascular system in polycystic ovary syndrome. Diabetes Care 2007",primary_citation,,Meyer C,2007,"Meyer C et al., 2007",10.2337/DC06-0618,,,,,10.2337/dc06-0618,,10.2337/dc06-0618,,Effects of Medical Therapy on Insulin Resistance and the Cardiovascular System in Polycystic Ovary Syndrome,,,,,,,,,0
838,837,4,4.4,111,"Moran LJ, Meyer C, Hutchison SK, Zoungas S, Teede HJ. Novel inflammatory markers in overweight women with or without polycystic ovary syndrome and following pharmacological intervention. Journal of Endocrinological Investigation 2010",primary_citation,,Moran LJ,2010,"Moran LJ et al., 2010",10.1007/BF03345790,,,,,10.1007/bf03345790,,10.1007/bf03345790,,Novel inflammatory markers in overweight women with and without polycystic ovary syndrome and following pharmacological intervention,,,,,,,,,0
845,844,4,4.4,111,"Kebapcilar, Levent; Yuksel, Arif; Bozkaya, Giray; Taner, Cuneyt Eftal; Kebapcilar, Ayse Gul; Bilgir, Oktay; Alacacioglu, Ahmet; Sari, Ismail Effects of an EE/CA compared with EE/CA-metformin on serum ADMA levels in women with polycystic ovary syndrome Central European journal of medicine 2009;4(4):423-427. ",primary_citation,,Kebapcilar,2009,"Kebapcilar et al., 2009",10.2478/s11536-009-0074-x,,,,,10.2478/s11536-009-0074-x,,10.2478/s11536-009-0074-x,,Effects of an EE/CA compared with EE/CA-metformin on serum ADMA levels in women with polycystic ovary syndrome,,,,,,,,,0
885,884,4,4.4,111,"Cetinkalp, S., Karadeniz, M., Erdogan, M., Ozgen, G., Saygl, F. and Ylmaz, C. 2009 The effects of rosiglitazone, metformin, and estradiol‐cyproterone acetate on lean patients with polycystic ovary syndrome. Endocrinologist. 2009 ",primary_citation,,Cetinkalp,2009,"Cetinkalp et al., 2009",10.1097/TEN.0B013E3181A58772,,,,,10.1097/ten.0b013e3181a58772,,10.1097/ten.0b013e3181a58772,,"The Effects of Rosiglitazone, Metformin, and Estradiol-Cyproterone Acetate on Lean Patients With Polycystic Ovary Syndrome",,,,,,,,,0
892,891,4,4.4,111,"Ahmad J, Shukla N, Khan AR, Ahmed F, Siddiqui MA. Comparisonof metabolic effects of metformin and rosiglitazone in the man-agement of polycystic ovary syndrome (PCOS): A prospective,parallel, randomized, open‐label study.Diabetes  Metab  Syndr:  ClinRes Rev. 2008 ",primary_citation,,Ahmad J,2008,"Ahmad J et al., 2008",10.1016/J.DSX.2007.12.003,,,,,10.1016/j.dsx.2007.12.003,,10.1016/j.dsx.2007.12.003,,"Comparison of metabolic effects of metformin and rosiglitazone in the management of polycystic ovary syndrome (PCOS): A prospective, parallel, randomized, open-label study",,,,,,,,,0
913,912,4,4.5,17,"Zheng, S., Zhang, Y., Long, T., Lu, J., Liu, X., Yan, J., . . . Wang, F. (2017). Short term monotherapy with exenatide is superior to metformin in weight loss, improving insulin resistance and inflammation in Chinese overweight/obese PCOS women. Obesity Medicine, 7, 15-20. doi:https://doi.org/10.1016/j.obmed.2017.06.003 (primary citation)",primary_citation,,Zheng,2017,"Zheng et al., 2017",10.1016/j.obmed.2017.06.003,,,,,10.1016/j.obmed.2017.06.003,,10.1016/j.obmed.2017.06.003,,"Short term monotherapy with exenatide is superior to metformin in weight loss, improving insulin resistance and inflammation in Chinese overweight/obese PCOS women",,,,,,,,,0
934,933,4,4.6,26,"Meyer C, McGrath BP, Teede HJ. Effects of medical therapy on insulin resistance and the cardiovascular system in polycystic ovary syndrome. Diabetes Care 2007;30(3):471-8. doi: 10.2337/dc06-0618.",primary_citation,,Meyer C,2007,"Meyer C et al., 2007",10.2337/dc06-0618,,,,,10.2337/dc06-0618,,10.2337/dc06-0618,,Effects of Medical Therapy on Insulin Resistance and the Cardiovascular System in Polycystic Ovary Syndrome,,,,,,,,,0
942,941,4,4.7,29,"Angik, Riju, Shubhada S. Jajoo, C. Hariharan, and Amogh Chimote. 2017. “A Comparative Study of Metabolic and Hormonal Effects of Myoinositol vs. Metformin in Women with Polycystic Ovary Syndrome: A Randomised Controlled Trial.” International Journal of Reproduction, Contraception, Obstetrics and Gynecology; Vol 4, No 1 (2015): January-February 2015. https://www.ijrcog.org/index.php/ijrcog/article/view/1838/1588.
",primary_citation,,Angik,2017,"Angik et al., 2017",10.5455/2320-1770.IJRCOG20150234,,,,,10.5455/2320-1770.ijrcog20150234,,10.5455/2320-1770.ijrcog20150234,,A COMPARATIVE STUDY OF METABOLIC AND HORMONAL EFFECTS OF MYOINOSITOL VS METFORMIN IN WOMEN WITH POLYCYSTIC OVARY SYNDROME: A RANDOMISED CONTROLLED TRIAL,,,,,,,,,0
946,945,4,4.7,29,"Chirania, Kishan, Sujata Misra, and Sandhya Behera. 2017. “A Randomised Clinical Trial Comparing Myoinositol and Metformin in PCOS.” International Journal of Reproduction, Contraception, Obstetrics and Gynecology; Vol 6, No 5 (2017): May 2017DO  - 10.18203/2320-1770.Ijrcog20171563. https://www.ijrcog.org/index.php/ijrcog/article/view/2671.
",primary_citation,,Chirania,2017,"Chirania et al., 2017",10.18203/2320-1770.Ijrcog20171563,,,,,10.18203/2320-1770.ijrcog20171563,,10.18203/2320-1770.ijrcog20171563,,A randomised clinical trial comparing myoinositol and metformin in PCOS,,,,,,,,,0
953,952,4,4.7,29,"Khan, R.B., M. Sarosh, and S. Anwer. 2022. “Role of Myo-Inositol and D-Chiro-Inositol in Improvement of Endocrine and Clinical Parameters in Teenage Girls Affected by PCOS: A Prospective Cohort Study.” Pakistan Journal of Medical and Health Sciences 16 (1): 21–24. https://doi.org/10.53350/pjmhs2216121.
",primary_citation,,Khan,2022,"Khan et al., 2022",10.53350/pjmhs2216121,,,,,,,,,Role of Myo-inositol and D-Chiro-Inositol in Improvement of Endocrine and Clinical Parameters in Girls affected by PCOS,,,,,,,,,0
954,953,4,4.7,29,"Maria Concetta Musacchio, Vincenzo De Leo. 2013. “A Combined Treatment with Myo-Inositol and Monacolin K Improve the Androgen and Lipid Profiles of Insulin-Resistant PCOS Patients.” J Metabolic Synd 02 (02). https://doi.org/10.4172/2167-0943.1000127.",primary_citation,,Maria Concetta Musacchio,2013,"Maria Concetta Musacchio et al., 2013",10.4172/2167-0943.1000127,,,,,10.4172/2167-0943.1000127,,10.4172/2167-0943.1000127,,A Combined Treatment with Myo-Inositol and Monacolin K Improve the Androgen and Lipid Profiles of Insulin-Resistant PCOS Patients,,,,,,,,,0
956,955,4,4.7,29,"Nehra, J., J. Kaushal, S.R. Singhal, and V.S. Ghalaut. 2017a. “A Comparative Study of Myo Inositol versus Metformin on Biochemical Profile in Polycystic Ovarian Syndrome in Women.” International Journal of Pharmaceutical Sciences and Research 8 (4): 1664–70. https://doi.org/10.13040/IJPSR.0975-8232.8(4).1664-70. (primary citation)",primary_citation,,Nehra,2017a,"Nehra et al., 2017a",10.13040/IJPSR.0975-8232.8(4).1664-70,,,,,,,,,,,,,,,,,,0
957,956,4,4.7,29,"Nehra, J., J. Kaushal, S.R. Singhal, and V.S. Ghalaut., 2017b. “Comparision of Myo-Inositol versus Metformin on Anthropometric Parameters in Polycystic Ovarian Syndrome in Women.” International Journal of Pharmacy and Pharmaceutical Sciences 9 (4): 144–48. https://doi.org/10.22159/ijpps.2017v9i4.16359.",samestudy_956,,Nehra,2017b,"Nehra et al., 2017b",10.22159/ijpps.2017v9i4.16359,,,,,10.22159/ijpps.2017v9i4.16359,,10.22159/ijpps.2017v9i4.16359,,COMPARISION OF MYO-INOSITOL VERSUS METFORMIN ON ANTHROPOMETRIC PARAMETERS IN POLYCYSTIC OVARIAN SYNDROME IN WOMEN,,,,,,,,,0
958,957,4,4.7,29,"Nestler, J.E., D.J. Jakubowicz, P. Reamer, R.D. Gunn, and G. Allan. 1999. “Ovulatory and Metabolic Effects of D-Chiro-Inositol in the Polycystic Ovary Syndrome.” New England Journal of Medicine 340 (17): 1314–20. https://doi.org/10.1056/NEJM199904293401703.
",primary_citation,,Nestler,1999,"Nestler et al., 1999",10.1056/NEJM199904293401703,,,,,10.1056/nejm199904293401703,,10.1056/nejm199904293401703,,Ovulatory and Metabolic Effects of d-<i>Chiro</i>-Inositol in the Polycystic Ovary Syndrome,,,,,,,,,0
1012,1011,4,4.10.,109,"Hu, S.; Leonard, A.; Seifalian, A.; et al. (2007): Vascular dysfunction during pregnancy in women with polycystic ovary syndrome. Human Reproduction 22, 6, 1532-1539. https://dx.doi.org/10.1093/humrep/dem028.",primary_citation,prior search,Hu,2007,"Hu et al., 2007",10.1093/humrep/dem028,,,,,10.1093/humrep/dem028,,10.1093/humrep/dem028,,Vascular dysfunction during pregnancy in women with polycystic ovary syndrome,,,,,,,,,0
1016,1015,4,4.10.,109,"Gupta, A.; Raina, K.; Kalkkar, T.; et al. (2009): Pregnancy outcome in women with the polycystic ovarian syndrome. JK Science 11, 2, 82-84, http://www.jkscience.org/archive/vol112/8%20Original%20Article-Pregnancy%20Outcome%20-.pdf",primary_citation,prior search,Gupta,2009,"Gupta et al., 2009",,,W2408925727,59140811.0,Pregnancy outcome in women with the polycystic ovarian syndrome,,,,,Pregnancy outcome in women with the polycystic ovarian syndrome,,,,,,,,,0
1025,1024,4,4.10.,109,"Nouh, A. A.; Shalaby, S. M. (2011): The predictive value of uterine blood flow in detecting the risk of adverse pregnancy outcome in patients with polycystic ovary syndrome. Middle East Fertility Society Journal 16, 4, 284-290. http://dx.doi.org/10.1016/j.mefs.2011.09.001.",primary_citation,prior search,Nouh,2011,"Nouh et al., 2011",10.1016/j.mefs.2011.09.001,,,,,10.1016/j.mefs.2011.09.001,,10.1016/j.mefs.2011.09.001,,The predictive value of uterine blood flow in detecting the risk of adverse pregnancy outcome in patients with polycystic ovary syndrome,,,,,,,,,0
1026,1025,4,4.10.,109,"Mehrabian, F.; Kelishadi, R. (2012): Comparison of the metabolic parameters and androgen level of umbilical cord blood in newborns of mothers with polycystic ovary syndrome and controls. Journal of Research in Medical Sciences 17, 3, 207-211, http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=prem&AN=23267369",primary_citation,prior search,Mehrabian,2012,"Mehrabian et al., 2012",,,W1953483834,24648982.0,Comparison of the metabolic parameters and androgen level of umbilical cord blood in newborns of mothers with polycystic ovary syndrome and controls,,,,,Comparison of the metabolic parameters and androgen level of umbilical cord blood in newborns of mothers with polycystic ovary syndrome and controls,,,,,,,,,0
1033,1032,4,4.10.,109,"Elkholi, D. G. E. Y.; Nagy, H. M. (2014): The effects of adipocytokines on the endocrino-metabolic features and obstetric outcome in pregnant obese women with polycystic ovary syndrome. Middle East Fertility Society Journal 19, 4, 293-302. http://dx.doi.org/10.1016/j.mefs.2014.02.001.",primary_citation,prior search,Elkholi,2014,"Elkholi et al., 2014",10.1016/j.mefs.2014.02.001,,,,,10.1016/j.mefs.2014.02.001,,10.1016/j.mefs.2014.02.001,,The effects of adipocytokines on the endocrino-metabolic features and obstetric outcome in pregnant obese women with polycystic ovary syndrome,,,,,,,,,0
1103,1102,5,5.1,65,"Abu-Fakher B, Al-Quobaili F, Alhalabi M. Follicular fluid antimullerian hormone (AMH) does not predict IVF outcomes in polycystic ovary syndrome patients. Middle East Fertility Society Journal. 2013;18(2):110-4.",primary_citation,,Abu-Fakher B,2013,"Abu-Fakher B et al., 2013",10.1016/J.MEFS.2012.12.005,,,,,10.1016/j.mefs.2012.12.005,,10.1016/j.mefs.2012.12.005,,Follicular fluid antimullerian hormone (AMH) does not predict IVF outcomes in polycystic ovary syndrome patients,,,,,,,,,0
1105,1104,5,5.1,65,"Al Safi WG, Hassan MF. Pregnancy rate in women with pcos with high lh/fsh ratio undergoing icsi. Latin American Journal of Pharmacy. 2021;40(Special Issue):336-40.",primary_citation,,Al Safi WG,2021,"Al Safi WG et al., 2021",,,,,Pregnancy rate in women with pcos with high lh/fsh ratio undergoing icsi,,,,,Pregnancy rate in women with pcos with high lh/fsh ratio undergoing icsi,,,,,,,,,0
1110,1109,5,5.1,65,"Bakir VL, Karahan G. Evaluation of obesity and metabolic status in polycystic ovary syndrome in fertile and infertile groups. Zeynep Kamil Tip Bulteni. 2019;50(2):44-8.",primary_citation,,Bakir VL,2019,"Bakir VL et al., 2019",10.16948/ZKTIPB.558143,,,,,10.16948/zktipb.558143,,10.16948/zktipb.558143,,Evaluation of Obesity and Metabolic Status in Polycystic Ovary Syndrome in Fertile and Infertile Groups,,,,,,,,,0
1213,1212,5,5.4,34,"Tang T, Glanville J, Hayden CJ, White D, Barth JH, Balen AH. Combined lifestyle modification and metformin in obese patients with polycystic ovary syndrome. A randomized, placebo-controlled, double-blind multicentre study. Hum Reprod. 2006 Jan;21(1):80-9. doi: 10.1093/humrep/dei311. Epub 2005 Sep 30 [Tang 2006b]",primary_citation,,Tang T,2006,"Tang T et al., 2006",10.1093/humrep/dei311,,,,,,,,,"Combined lifestyle modification and metformin in obese patients with polycystic ovary syndrome. A randomized, placebo-controlled, double-blind multicentre study",,,,,,,,,0
1226,1225,5,5.5,12,"Yadav P, Singh S, Singh R, Jain M, Awasthi S, Raj P. To study the effect on fertility outcome by gonadotropins vs laparoscopic ovarian drilling in clomiphene-resistant cases of polycystic ovarian syndrome. Journal of SAFOG 2017; 9(4): 336‐340.",primary_citation,,Yadav P,2017,"Yadav P et al., 2017",10.5005/JP-JOURNALS-10006-1525,,,,,10.5005/jp-journals-10006-1525,,10.5005/jp-journals-10006-1525,,To Study the Effect on Fertility Outcome by Gonadotropins vs Laparoscopic Ovarian Drilling in Clomiphene-resistant Cases of Polycystic Ovarian Syndrome,,,,,,,,,0
1230,1229,5,5.6,6,"Farquhar CM, Williamson K, Gudex G, Johnson NP, Garland J, Sadler L. A randomized controlled trial of laparoscopic ovarian diathermy versus gonadotropin therapy for women with clomiphene citrate-resistant polycystic ovary syndrome. Fertil Steril. 2002 Aug;78(2):404-11. doi: 10.1016/s0015-0282(02)03225-9.",primary_citation,,Farquhar CM,2002,"Farquhar CM et al., 2002",10.1016/s0015-0282(02)03225-9,,,24959997.0,,,,,,A randomized controlled trial of laparoscopic ovarian diathermy versus gonadotropin therapy for women with clomiphene citrate-resistant polycystic ovary syndrome,,,,,,,,,0
1232,1231,5,5.6,6,"Sharma, M., Kriplani, A., & Agarwal, N. (2006). Laparoscopic bipolar versus unipolar ovarian drilling in infertile women with resistant polycystic ovarian syndrome: a pilot study. Journal of gynecologic surgery, 22(3), 105-111.",primary_citation,,Sharma,2006,"Sharma et al., 2006",10.1089/GYN.2006.22.105,,,,,10.1089/gyn.2006.22.105,,10.1089/gyn.2006.22.105,,Laparoscopic Bipolar Versus Unipolar Ovarian Drilling in Infertile Women with Resistant Polycystic Ovarian Syndrome: A Pilot Study,,,,,,,,,0
1233,1232,5,5.6,6,"Yadav P, Singh S, Singh R, Jain M, Awasthi S, Raj P. To study the effect on fertility outcome by gonadotropins vs laparoscopic ovarian drilling in clomiphene-resistant cases of polycystic ovarian syndrome. Journal of SAFOG 2017; 9(4): 336‐340.",primary_citation,,Yadav P,2017,"Yadav P et al., 2017",10.5005/JP-JOURNALS-10006-1525,,,,,10.5005/jp-journals-10006-1525,,10.5005/jp-journals-10006-1525,,To Study the Effect on Fertility Outcome by Gonadotropins vs Laparoscopic Ovarian Drilling in Clomiphene-resistant Cases of Polycystic Ovarian Syndrome,,,,,,,,,0
1234,1233,5,5.7.1,7,"Ashrafi, Mahnaz & Moini, Ashraf & Mohammadzadeh, Afsaneh & Ezabadi, Zahra & Zafarani, Fatemeh & Baghestani, Ahmad. (2005). A comparative study of GnRH antagonist and GnRH agonist in PCO patients undergoing IVF/ICSI cycles. Iranian Journal of Reproductive Medicine (ISSN: 1680-6433) Vol 3 Num 1. 3. ",primary_citation,,Ashrafi,2005,"Ashrafi et al., 2005",,,W2162847277,54603939.0,A comparative study of GnRH antagonist and GnRH agonist in PCO patients undergoing IVF/ICSI cycles. Iranian Journal of Reproductive Medicine,,,,,A comparative study of GnRH antagonist and GnRH agonist in PCO patients undergoing IVF/ICSI cycles. Iranian Journal of Reproductive Medicine,,,,,,,,,0
